Double blind comparison of lithium and verapamil in cluster headache prophylaxis

G. Bussone, M. Leone, C. Peccarisi, G. Micieli, F. Granella, M. Magri, G. C. Manzoni, G. Nappi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Chronic Cluster Headache (CCH) treatment is troublesome; since there are no pain-free periods, it must be continuous. The most effective CCH prophylactic drug today is lithium carbonate but long-term use of this drug is limited by the possibility of side effects. Recently, calcium antagonists have been successfully employed to prevent migraine, and preliminary studies also indicate that verapamil in particular is an efficacious treatment for CCH. We have conducted a multicenter trial employing a double-dummy, double blind, cross-over protocol, comparing verapamil with the established efficacy of lithium carbonate, in preventing CCH attacks. Both lithium carbonate and verapamil were effective in preventing CCH but verapamil caused fewer side effects and had a shorter latency period. We did not observe any correlation between plasma levels of the two drugs and their clinical efficacy. Both the drugs tested here may exert their effect by restoring a normal inhibitory tone to the pain modulating pathways from the trigemino-vascular system, a circuit putatively implicated in CCH.

Original languageEnglish
Title of host publicationHeadache
Pages411-417
Number of pages7
Volume30
Edition7
Publication statusPublished - 1990

Fingerprint

Cluster Headache
Verapamil
Lithium
Lithium Carbonate
Pharmaceutical Preparations
Migraine Disorders
Multicenter Studies
Blood Vessels
Calcium
Pain
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Bussone, G., Leone, M., Peccarisi, C., Micieli, G., Granella, F., Magri, M., ... Nappi, G. (1990). Double blind comparison of lithium and verapamil in cluster headache prophylaxis. In Headache (7 ed., Vol. 30, pp. 411-417)

Double blind comparison of lithium and verapamil in cluster headache prophylaxis. / Bussone, G.; Leone, M.; Peccarisi, C.; Micieli, G.; Granella, F.; Magri, M.; Manzoni, G. C.; Nappi, G.

Headache. Vol. 30 7. ed. 1990. p. 411-417.

Research output: Chapter in Book/Report/Conference proceedingChapter

Bussone, G, Leone, M, Peccarisi, C, Micieli, G, Granella, F, Magri, M, Manzoni, GC & Nappi, G 1990, Double blind comparison of lithium and verapamil in cluster headache prophylaxis. in Headache. 7 edn, vol. 30, pp. 411-417.
Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. In Headache. 7 ed. Vol. 30. 1990. p. 411-417
Bussone, G. ; Leone, M. ; Peccarisi, C. ; Micieli, G. ; Granella, F. ; Magri, M. ; Manzoni, G. C. ; Nappi, G. / Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache. Vol. 30 7. ed. 1990. pp. 411-417
@inbook{38fabc305bd54ee2b04a29c7a8638631,
title = "Double blind comparison of lithium and verapamil in cluster headache prophylaxis",
abstract = "Chronic Cluster Headache (CCH) treatment is troublesome; since there are no pain-free periods, it must be continuous. The most effective CCH prophylactic drug today is lithium carbonate but long-term use of this drug is limited by the possibility of side effects. Recently, calcium antagonists have been successfully employed to prevent migraine, and preliminary studies also indicate that verapamil in particular is an efficacious treatment for CCH. We have conducted a multicenter trial employing a double-dummy, double blind, cross-over protocol, comparing verapamil with the established efficacy of lithium carbonate, in preventing CCH attacks. Both lithium carbonate and verapamil were effective in preventing CCH but verapamil caused fewer side effects and had a shorter latency period. We did not observe any correlation between plasma levels of the two drugs and their clinical efficacy. Both the drugs tested here may exert their effect by restoring a normal inhibitory tone to the pain modulating pathways from the trigemino-vascular system, a circuit putatively implicated in CCH.",
author = "G. Bussone and M. Leone and C. Peccarisi and G. Micieli and F. Granella and M. Magri and Manzoni, {G. C.} and G. Nappi",
year = "1990",
language = "English",
volume = "30",
pages = "411--417",
booktitle = "Headache",
edition = "7",

}

TY - CHAP

T1 - Double blind comparison of lithium and verapamil in cluster headache prophylaxis

AU - Bussone, G.

AU - Leone, M.

AU - Peccarisi, C.

AU - Micieli, G.

AU - Granella, F.

AU - Magri, M.

AU - Manzoni, G. C.

AU - Nappi, G.

PY - 1990

Y1 - 1990

N2 - Chronic Cluster Headache (CCH) treatment is troublesome; since there are no pain-free periods, it must be continuous. The most effective CCH prophylactic drug today is lithium carbonate but long-term use of this drug is limited by the possibility of side effects. Recently, calcium antagonists have been successfully employed to prevent migraine, and preliminary studies also indicate that verapamil in particular is an efficacious treatment for CCH. We have conducted a multicenter trial employing a double-dummy, double blind, cross-over protocol, comparing verapamil with the established efficacy of lithium carbonate, in preventing CCH attacks. Both lithium carbonate and verapamil were effective in preventing CCH but verapamil caused fewer side effects and had a shorter latency period. We did not observe any correlation between plasma levels of the two drugs and their clinical efficacy. Both the drugs tested here may exert their effect by restoring a normal inhibitory tone to the pain modulating pathways from the trigemino-vascular system, a circuit putatively implicated in CCH.

AB - Chronic Cluster Headache (CCH) treatment is troublesome; since there are no pain-free periods, it must be continuous. The most effective CCH prophylactic drug today is lithium carbonate but long-term use of this drug is limited by the possibility of side effects. Recently, calcium antagonists have been successfully employed to prevent migraine, and preliminary studies also indicate that verapamil in particular is an efficacious treatment for CCH. We have conducted a multicenter trial employing a double-dummy, double blind, cross-over protocol, comparing verapamil with the established efficacy of lithium carbonate, in preventing CCH attacks. Both lithium carbonate and verapamil were effective in preventing CCH but verapamil caused fewer side effects and had a shorter latency period. We did not observe any correlation between plasma levels of the two drugs and their clinical efficacy. Both the drugs tested here may exert their effect by restoring a normal inhibitory tone to the pain modulating pathways from the trigemino-vascular system, a circuit putatively implicated in CCH.

UR - http://www.scopus.com/inward/record.url?scp=0025080824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025080824&partnerID=8YFLogxK

M3 - Chapter

C2 - 2205598

AN - SCOPUS:0025080824

VL - 30

SP - 411

EP - 417

BT - Headache

ER -